
|Articles|August 14, 2012
Individualized therapy - The modern standard in wet AMD care
Novartis sponsored a symposium at the COPHy congress in 2012 exploring the current treatment issues surrounding wet AMD. This supplement reveals the highlights of the meeting.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Why ST-100 is expanding from dry eye into corneal wound healing
2
ONL Therapeutics completes enrollment in Phase 2 GALAXY trial for geographic atrophy
3
Eichenbaum Acorns: Building the private academic model with Jeffrey S. Heier, MD
4
Water-soluble CBD eye drops lower IOP and dampen corneal sensitivity in glaucoma mouse model
5
















